Menu

Baudax Bio, Inc. BXRXQ

Full chart Compare
Set alert

Price alert · BXRXQ

All alert types
0.00 USD 0.00 (+0.00%)

At closeNov 9, 2026, 4:00 PM EST

0.0001 Day range 0.0001
0.00001 52-week range 0.0001
YTD
+900.00%
1 year
+900.00%

Revenue & Expenses

Other Income → Expenses: $786.00KExpenses → Gross Loss: $5.74MExpenses → Selling, General & Admin: $24.12MExpenses → Research & Development: $3.89MExpenses → Other Operating Expenses: $25.84MNet Loss → Expenses: $58.80MRevenue → Cost of Revenue: $1.27MOther Income$786.00KNet Loss$58.80MCost of Revenue$7.01MExpenses$59.58MGross Loss$5.74MSelling, General & Admin$24.12MResearch & Development$3.89MOther Operating Expenses$25.84MRevenue$1.27M

Latest period ending Dec 31, 2022 · select a line to chart its full history

BXRXQ annual income statement
Fiscal yearFY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018
1.27M1.08M493.00K00
-5.74M-1.36M-1.24M00
-59.58M-52.38M-55.81M-47.07M-65.04M
-58.80M-19.77M-76.10M-32.56M-73.67M
-177.30-361.16-5,714.80-4,872.01-11,032.01
BXRXQ annual balance sheet
Fiscal yearFY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018
5.26M15.89M30.34M17.74M0
10.03M53.28M68.73M54.21M35.02M
34.27M40.05M83.53M70.93M103.37M
7.93M8.53M9.15M773.00K0
-24.24M13.23M-14.80M-16.72M-68.35M
BXRXQ annual cash flow
Fiscal yearFY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018
-27.79M-49.27M-44.06M-50.04M-59.75M
-20.00K-194.00K-639.00K-1.48M-3.45M
17.18M35.01M57.30M69.27M63.20M
-20.00K-203.00K-639.00K-1.48M-3.45M
-10.63M-14.45M12.60M17.74M0